Thermo Fisher Scientific Share Price Xetra
Equities
TN8
US8835561023
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
550.3 EUR | +0.35% | +2.51% | +13.98% |
Sales 2024 * | 43.01B 39.61B 3,400B | Sales 2025 * | 46.08B 42.44B 3,642B | Capitalization | 227B 209B 17,947B |
---|---|---|---|---|---|
Net income 2024 * | 6.11B 5.63B 483B | Net income 2025 * | 7B 6.45B 553B | EV / Sales 2024 * | 5.84 x |
Net Debt 2024 * | 23.99B 22.1B 1,896B | Net Debt 2025 * | 19.18B 17.67B 1,516B | EV / Sales 2025 * | 5.34 x |
P/E ratio 2024 * |
37.6
x | P/E ratio 2025 * |
32
x | Employees | 122,000 |
Yield 2024 * |
0.25% | Yield 2025 * |
0.27% | Free-Float | 86.04% |
Latest transcript on Thermo Fisher Scientific
1 day | +0.36% | ||
1 week | +2.51% | ||
Current month | +2.03% | ||
1 month | +3.55% | ||
3 months | +7.94% | ||
6 months | +26.19% | ||
Current year | +13.98% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 31/10/01 |
Director of Finance/CFO | 57 | 31/05/01 | |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 31/10/01 |
C. Harris
BRD | Director/Board Member | 67 | 29/03/12 |
Ruby Chandy
BRD | Director/Board Member | 62 | 28/02/22 |
Date | Price | Change | Volume |
---|---|---|---|
15/05/24 | 547.9 | -0.09% | 271 |
14/05/24 | 548.4 | +0.22% | 424 |
13/05/24 | 547.2 | -0.58% | 25 |
10/05/24 | 550.4 | +3.01% | 119 |
09/05/24 | 534.3 | -0.04% | 12 |
Delayed Quote Xetra, May 15, 2024 at 04:02 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.87% | 192B | |
+17.22% | 136B | |
+28.96% | 108B | |
+1.44% | 64.07B | |
+17.61% | 52.1B | |
+6.74% | 51.87B | |
+9.79% | 44.33B | |
+5.06% | 36.75B | |
+27.74% | 31.71B |
- Stock Market
- Equities
- TMO Stock
- TN8 Stock